(64) claimed that PAX5 deletions were unsuitable for an independent prognostic marker for predicting prognosis because of no significant influence of RFS among B-ALL subgroups (P = 0.6839). This evidence concerns the gene PAX5 and acute lymphoblastic leukemia.